dementia
Constantiam Bio Gets $485K Grant From National Institute on Aging for Alzheimer's Tool Development
The funding will be used to advance a tool for interpreting risk variants associated with Alzheimer’s disease and related dementias.
Roche Nabs FDA Clearance for Alzheimer's Assays
The cerebrospinal fluid-based immunoassays provide ratios that reflect pathologies of Alzheimer's disease and can aid earlier diagnosis.
CND Life Sciences Closes $4.5M Series Seed 3 Financing Round
The company will use the funding to accelerate commercialization of its Syn-One test for identifying abnormal alpha-synuclein aggregation via skin biopsy.
CND Life Sciences, Beth Israel Ink Licensing Deal for Neurodegenerative Disease Test Technology
The agreement gives CND access to technologies key to CND's skin biopsy-based test for the hallmarks of the synucleinopathy family of neurodegenerative diseases.
Metabolon Partners With Swedish Biofinder 2 Study to Develop Dementia Biomarkers
The company will run metabolomics on cerebrospinal fluid and plasma from the study's baseline collections to identify biomarkers.